EMA, Pfizer bivalent vaccine evaluation begins

EMA Pfizer bivalent vaccine evaluation begins

(Finance) – They are 31,088 i new Coronavirus positives in Italy in the last 24 hours compared to just over 208,000 swabs carried out, with the positivity rate at 14.9%.

This is what emerges from the daily bulletin issued by the Ministry of Health according to which 98 deaths (yesterday 60) in the last 24 hours, for a total of 175,505 victims since the beginning of the pandemic. In terms of hospitalizations, there are 5,427 (204 fewer than yesterday) hospitalized with symptoms, of which 226 in intensive care (-3).

The European Medicines Agency Ema has started to evaluate the authorization request for a bivalent version of the anti-Covid Comirnaty vaccine. Pfizer-BioNTech, adapted to cover the original Sars-CoV-2 strain and Omicron subvariants 4 and 5 (BA.4 / 5). This was announced by the EU regulatory body via Twitter.

meanwhile, the WHO raises the level of alert and warns: within “a few weeks, the European Region is expected to reach 250 million confirmed cases of Covid-19 since the beginning of the pandemic two and a half years ago. As autumn-winter approaches, we expect an increase in cases, with or without a resurgence of seasonal flu in the EU. “These are the words of WHO Europe director, Hans Kluge, at a press conference.

“We have made great strides against the pandemic but the virus is circulating widely, causing hospitalizations and still too many preventable deaths: about 3,000 in the last week alone, one third of the world total. The virus is still evolving to evade our countermeasures. ”

tlb-finance